AAAAAA

   
Results: 1-9 |
Results: 9
ADJUVANT INTRAPLEURAL AMPHOTERICIN-B THERAPY FOR PULMONARY MUCORMYCOSIS IN A CARDIAC ALLOGRAFT RECIPIENT
Authors: KFOURY AG SMITH JC FARHOUD HH TERREROS DA STRINGHAM JC TAYLOR DO RENLUND DG
Citation: Ag. Kfoury et al., ADJUVANT INTRAPLEURAL AMPHOTERICIN-B THERAPY FOR PULMONARY MUCORMYCOSIS IN A CARDIAC ALLOGRAFT RECIPIENT, Clinical transplantation, 11(6), 1997, pp. 608-612
MECHANICAL CIRCULATORY SUPPORT - CANDIDATE SELECTION, BENEFITS, AND POTENTIAL COMPLICATIONS (VOL 10, PG 343, 1997)
Authors: KFOURY AG ANDERSON JL TAYLOR DO
Citation: Ag. Kfoury et al., MECHANICAL CIRCULATORY SUPPORT - CANDIDATE SELECTION, BENEFITS, AND POTENTIAL COMPLICATIONS (VOL 10, PG 343, 1997), Journal of interventional cardiology, 10(6), 1997, pp. 3-3
MECHANICAL CIRCULATORY SUPPORT - CANDIDATE SELECTION, BENEFITS, AND POTENTIAL COMPLICATIONS
Authors: KFOURY AG ANDERSON JL TAYLOR DO
Citation: Ag. Kfoury et al., MECHANICAL CIRCULATORY SUPPORT - CANDIDATE SELECTION, BENEFITS, AND POTENTIAL COMPLICATIONS, Journal of interventional cardiology, 10(5), 1997, pp. 343-348
ANTILYMPHOCYTE-ANTIBODY PROPHYLAXIS - REVIEW OF THE ADULT EXPERIENCE IN HEART-TRANSPLANTATION
Authors: TAYLOR DO KFOURY AG PISANI B HAMMOND EH RENLUND DG
Citation: Do. Taylor et al., ANTILYMPHOCYTE-ANTIBODY PROPHYLAXIS - REVIEW OF THE ADULT EXPERIENCE IN HEART-TRANSPLANTATION, Transplantation proceedings, 29(8A), 1997, pp. 13-15
INCIDENCE OF ADENOMATOUS COLORECTAL POLYPS IN CARDIAC TRANSPLANT RECIPIENTS
Authors: RODRIGUEZLARRAIN JM ZIEBERT JJ KFOURY AG KUWADA S TAYLOR DO RENLUND DG
Citation: Jm. Rodriguezlarrain et al., INCIDENCE OF ADENOMATOUS COLORECTAL POLYPS IN CARDIAC TRANSPLANT RECIPIENTS, Transplantation, 64(3), 1997, pp. 528-530
INCREASED INCIDENCE OF ALLOGRAFT-REJECTION IN STABLE HEART-TRANSPLANTRECIPIENTS AFTER CONVERSION FROM MYCOPHENOLATE MOFETIL TO AZATHIOPRINE
Authors: SHARMA RC KFOURY AG TAYLOR DO DUNNDRAGER D RENLUND DG
Citation: Rc. Sharma et al., INCREASED INCIDENCE OF ALLOGRAFT-REJECTION IN STABLE HEART-TRANSPLANTRECIPIENTS AFTER CONVERSION FROM MYCOPHENOLATE MOFETIL TO AZATHIOPRINE, Circulation, 96(8), 1997, pp. 346-346
PREVALENCE OF SKELETAL COMPLICATIONS IN SYMPTOMATIC HEART-TRANSPLANT RECIPIENTS
Authors: SHARMA RC KFOURY AG TAYLOR DO RENLUND DG
Citation: Rc. Sharma et al., PREVALENCE OF SKELETAL COMPLICATIONS IN SYMPTOMATIC HEART-TRANSPLANT RECIPIENTS, Circulation, 96(8), 1997, pp. 2854-2854
MYCOPHENOLATE MOFETIL (MMF) IN HEART-TRANSPLANTATION - REJECTION PREVENTION AND TREATMENT
Authors: RENLUND DG GOPINATHAN SK KFOURY AG TAYLOR DO
Citation: Dg. Renlund et al., MYCOPHENOLATE MOFETIL (MMF) IN HEART-TRANSPLANTATION - REJECTION PREVENTION AND TREATMENT, Clinical transplantation, 10(1), 1996, pp. 136-139
FIXED PULMONARY-HYPERTENSION IN PATIENTS WITH END-STAGE HEART-FAILURECONSIDERED FOR HEART-TRANSPLANTATION - HOW FIXED IS IT
Authors: FARHOUD HH KFOURY AG RENLUND DG TAYLOR DO
Citation: Hh. Farhoud et al., FIXED PULMONARY-HYPERTENSION IN PATIENTS WITH END-STAGE HEART-FAILURECONSIDERED FOR HEART-TRANSPLANTATION - HOW FIXED IS IT, Circulation, 94(8), 1996, pp. 2799-2799
Risultati: 1-9 |